Effects of Tripterygium wilfordii Hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production

Arthritis and Rheumatism

Volumn 41, Issue 1, 1998, Pages 130-138

  Tao, Xuelian ^a   Schulze Koops, Hendrik ^a   Ma, Li ^a   Cai, Jian ^a   Mao, Yanping ^a   Lipsky, Peter E ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; CHLOROFORM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEXAMETHASONE; DIMETHYL SULFOXIDE; INDOMETACIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; METHANOL; PHYTOHEMAGGLUTININ; PROSTAGLANDIN E2; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; HISTIOCYTE; HUMAN; HUMAN CELL; MONOCYTE; NEWBORN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RHEUMATOID ARTHRITIS; SKIN FIBROBLAST; SYNOVIOCYTE; TABLET;

ACETATES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHLOROFORM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DITERPENES; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; ISOENZYMES; KINETICS; LIPOPOLYSACCHARIDES; LYMPHOMA, LARGE-CELL; MEMBRANE PROTEINS; METHANOL; MONOCYTES; PEROXIDASES; PHENANTHRENES; PLANT EXTRACTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TRIPTERYGIUM; TUMOR CELLS, CULTURED;

EID: 0031982941     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199801)41:1<130::AID-ART16>3.0.CO;2-4     Document Type: Article

References (37)

1. Lipsky PE, Tao XL. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum 1997;26:713-23.
2. Tao X, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum 1991;34:1274-81.
3. Tao XL, Cai JJ, Lipsky PE. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanal extract (T2) of Tripterygium wilfordii Hook F. J Pharmacol Exp Ther 1995;272:1305-12.
4. Tao XL, Davis LS, Hashimoto K, Lipsky PE. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction. J Pharmacol Exp Ther 1996;2786:316-25.
5. Zheng JR, Xu LF, Ma L, Wang DH, Gao JW. Studies on pharmacological actions of total glycisides in Tripterygium wilfordii. Acta Academiae Medicimae Sinicae 1983;5:1-7.
6. Li LZ, Chen SF, Tan GP, Yang J, Zhang SF, Zhang LX, et al. Pharmacological studies of the ethyl acetate extract of Tripterygium wilfordii Hook. Zhong Cao Yao 1982;13:27-32.
7. Cai JJ, Tao XL, Lipsky PE. High performance liquid chromatography determination of triptolide and tripdiolide in acetate extract of Tripterygium wilfordii Hook F. J Liquid Chromatogr 1994;17:4479-87.
8. Li LZ, Chen SF, Wong FJ, Yang J, Tan GP, Xu YJ, et al. Effect of triptolide on inflammation and immune functions. Acta Chin Pharmacol 1886;2:25-8.
9. 2. Acta Academiae Medicimae Sinicae 1989;11:37-40.
10. Patrono C. Pharmacologic modulation of the cyclooxygenase pathway in the human kidney. Adv Prostaglandin Thromboxane Leukot Res 1990;20:250-6.
11. Smith WL, Meade EA, Dewitt DL. Pharmacology of prostaglandin endoperoxide synthase isoformes-1 and -2. Ann N Y Acad Sci 1993;714:137-42.
12. Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990;265:16737-40.
13. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 1992;89:7384-8.
14. Dubois RN, Tsujii M, Bishop P, Awad JA, Makita K, Lanahan AA. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 1994;266:G822-7.
15. Pritchard KA Jr, O'Bannion MK, Miano JM, Vlasic N, Bhatia UG, Young DA. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem 1994;269:8504-9.
16. Szczepanski A, Moatter T, Carley WW, Gerritsen ME. Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1: inhibition by glucocorticoids. Arthritis Rheum 1994;37:495-503.
17. Liu SF, Newton R, Evans TW, Barnes PJ. Differential regulation of cyclooxygenase-1 and cyclooxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci 1996;90:301-6.
18. Geng Y, Blanco FJ, Cornelisson M, Lotz M. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 1995;155:796-801.
19. Masferrer JL, Reddy ST, Zweifel BS, Seibert K, Needleman P, Gilbert RS, et al. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J Pharmacol Exp Ther 1994;270:1340-4.
20. Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS. Elevated Th1-or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol 1995;155:5029-37.
21. Schulze-Koops H, Davis LS, Kavanaugh AF, Lipsky PE. Elevated cytokine messenger RNA levels in the peripheral blood in patients with rheumatoid arthritis suggest different degrees of myeloid cell activation. Arthritis Rheum 1997;40:639-47.
22. Smith WL. Prostanoid biosynthesis and mechanism of action. Am J Physiol 1992;263:F181-91.
23. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest 1994;93:1095-100.
24. Seibert K, Masferrer JL. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor 1994;4:17-23.
25. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996;390:165-9.
26. Kargman S, Wong E, Greig GM, Falgueyret JP, Cromlish W, Ethier D, et al. Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells. Biochem Pharmacol 1996;52:1113-25.
27. Masferrer JL, Zweifla BS, Msnning PT, Hauser SD, Leahy KM, Smith WG. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A 1994;91:3228-32.
28. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-54.
29. Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract: the double-edged sword. Arthritis Rheum 1995;38:5-18.
30. Tao XL, Sun Y, Zhang NZ. Treatment of rheumatoid arthritis with low dose of T2. Zhong Xi Yi Gie He Zai Zi 1990;10:289-90.
31. Dewitt DL, Meade EA. Serum and glucocorticoid regulation of gene transcription and expression of the postaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys 1993;306:94-1020.
32. O'Banion MK, Sadowski HB, Winn V, Young DA. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-7.
33. Baily JM. Regulation of cyclooxygenase synthesis by EGF and corticosteroids. Adv Prostglandin Thromboxane Leukot Res 1989;19:450-7.
34. Raz A, Wyche A, Fu J, Seibert K, Needleman P. Regulation of prostaglandins synthesis in human fibroblasts and human blood monocytes by interleukin-1, endotoxin, and glucocorticoids. Adv Prostaglandin Thromboxane Leukot Res 1990;20:22-7.
35. O'Sullivan MG, Huggins EM, McCal CE. Lipopolisaccharide-induced expression of prostaglandin H synthase-2 in alveolar macrophages is inhibited by dexamthasone but not by aspirin. Biochem Biophys Res Commun 1993;191:1294-300.
36. Winn VD, O'Banion MK, Young DA. Anti-inflammatory glucocorticoid action: inhibition of griPGHS, a new cyclooxygenase. J Lipid Mediat Cell Signal 1993;6:101-11.
37. Schaefers HZ, Goppelt-Struebe UE. Inteference of corticosteroids with prostaglandin E2 synthesis at the level of cyclooxygenase-2 mRNA expression in kidney cells. Biochem Pharmacol 1996;52:1415-21.